Pro Medicus Limited

ASX (AUD): Pro Medicus Limited (PME)

Last Price

130.97

Today's Change

-0.40 (0.30%)

Day's Change

128.82 - 132.00

Trading Volume

263,126

Overview

Market Cap

13 Billion

Shares Outstanding

104 Million

Avg Volume

378,146

Avg Price (50 Days)

127.38

Avg Price (200 Days)

103.95

PE Ratio

195.48

EPS

0.67

Earnings Announcement

13-Aug-2024

Previous Close

131.37

Open

129.50

Day's Range

128.82 - 132.0

Year Range

65.155 - 144.34

Trading Volume

263,126

Price Change Highlight

1 Day Change

-0.30%

5 Day Change

-1.50%

1 Month Change

-4.04%

3 Month Change

27.20%

6 Month Change

31.38%

Ytd Change

36.00%

1 Year Change

99.10%

3 Year Change

120.23%

5 Year Change

341.87%

10 Year Change

14213.66%

Max Change

11288.70%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Health Information Services

Description:

Pro Medicus Limited engages in the development and supply of healthcare imaging software and services to hospitals, diagnostic imaging groups, and other related health entities in Australia, North America, and Europe. The company offers radiology information systems (RIS), a proprietary medical software for practice management, training, installation, professional services, and after-sale support and service products; and Promedicus.net, an e-health platform. It also provides healthcare imaging software that provides radiologists and clinicians with visualization capability for viewing 2-D, 3-D, and 4-D medical images, as well as picture archive and communication system (PACS)/digital imaging software; and integration products. In addition, the company offers Visage Ease Pro, a mobile application that provides users the ability to interpret various diagnostic imaging studies stored on a Visage 7 server. The company provides its products under the Visage RIS, Visage RIS/PACS, Visage 7, Visage Ease Pro, and Visage Ease names. Pro Medicus Limited was incorporated in 1983 and is headquartered in Richmond, Australia.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment